| May 4 | |
| DNA Damage Responses: Bedside to Bench to Bedside | Michael B. Kastan, M.D., Ph.D. Executive Director Duke Cancer Institute Professor, Pharmacology and Cancer Biology Duke University Medical Center |
| May 11 | |
| In Vivo Modeling of Prostate Cancer Tumor Initiating Cells and Castration Resistance | Kathleen Kelly, Ph.D. Chief Cell and Cancer Biology Branch Center for Cancer Research, NCI |
| May 18 | |
| T Cell Tolerance to Prostate Cancer Antigens: Lessons Learned from a TRAMP (mouse) |
Arthur Andrew Hurwitz, Ph.D. Head Tumor Immunity and Tolerance Group Laboratory of Molecular Immunoregulation Frederick National Laboratory for Cancer Research |
| May 25 | |
| No Lecture – Memorial Day weekend begins | |
General information about Grand Rounds
Lipsett Amphitheater, Building 10, Fridays, 12:00–1:00 p.m.
Telephone contact: 301-496-4345
Educational Objectives
After attending this activity, the participant should be able to describe the novel aspects of the basic and/or clinical research in cancer prevention, diagnosis, or treatment presented by the speaker. Participants should also be able to discuss the potential applications of the research and/or therapeutic approaches presented by the speaker and the impact that this is likely to have in advancing the field of oncology research and practice.
If you are an individual with a disability who needs any assistance or assistive devices to participate in this event, please call Romi Sawhney at 301-496-4345 three days prior to the seminar so that we can discuss your needs.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
Back to Top
